Senior insider sale
Chief Medical Officer at METAGENOMI THERAPEUTICS, INC. — senior position signals high conviction
$68.1K
35.83K shares
What this filing means
NOONBERG SARAH B. plans to sell 35.83K shares of METAGENOMI THERAPEUTICS, INC. valued at approximately $68.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/11/2025ACC: 0002007317-25-001071
Officer· Chief Medical Officer
Since Feb 2024
35.83K
Shares to sell
$68.1K
Approx. market value
35.83K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
STOCK AWARD
CASH
6/5/2025
9.20KSTOCK AWARD
CASH
1/30/2003
26.63KTotal acquired35.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/5/2025 | STOCK AWARD CASH | 9.20K | — |
1/30/2003 | STOCK AWARD CASH | 26.63K | — |
| Total | 35.83K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
35.83K
Market value
$68.1K
9/11/2025
Total
Units
35.83K
Value
$68.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/11/2025 | 35.83K | $68.1K | NASDAQ | Planned |
| Total | 35.83K | $68.1K | ||